Detailansicht

Wissensnetz

Person

Thomas Thum (1974-)

Arzt

Name	Thomas Thum
Zeit	1974- (Lebensdaten)
Ort	Hannover (2001-2004) (Wirkungsort) Würzburg (2004-2009) (Wirkungsort) Hannover (2009-) (Wirkungsort) Deutschland
Akademischer Grad bzw. Titel	Prof. Dr. Dr. med.
Beruf	Arzt (charakteristischer Beruf) Direktor
Beziehung	Medizinische Hochschule Hannover Institut für Molekulare und Translationale Therapiestrategien (Hannover) (Direktor) Integriertes Forschungs- und Behandlungszentrum Transplantation
Weitere Angaben	Diss. Medizinische Hochschule (2001)
Datensatztyp	Person
GND-Nummer	123268605
Datensatz-ID	123268605
Beteiligt an alle anzeigen SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation Telomerase is essential for cardiac differentiation and sustained metabolism of human cardiomyocytes Circular RNA circZFPM2 regulates cardiomyocyte hypertrophy and survival Dextrans, Pullulan and Lentinan, New Scaffold Materials for Use as Hydrogels in Tissue Engineering Circulating miR-let7a levels predict future diagnosis of chronic thromboembolic pulmonary hypertension A pilot study for risk stratification of ventricular tachyarrhythmia in hypertrophic cardiomyopathy with routine echocardiography parameters Macrophage-based therapeutic approaches for cardiovascular diseases Contribution of human stem cell-derived cardiomyocyte subtypes to bioartificial cardiac tissue formation and function Dextrans, Pullulan and Lentinan, New Scaffold Materials for Use as Hydrogels in Tissue Engineering Activation of the integrated stress response rewires cardiac metabolism in Barth syndrome Circulating miR-133a-3p defines a low-risk subphenotype in patients with heart failure and central sleep apnea: a decision tree machine learning approach Skeletal muscle fiber hypercontraction induced by Bothrops asper myotoxic phospholipases A2 ex vivo does not involve a direct action on the contractile apparatus Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems Characterization of circular RNA circZFPM2 as therapeutic target in hypertrophic cardiomyopathy Investigating the clinical benefit of circulating long non-coding RNAs to improve the specificity of high-sensitive Troponin T in patients with ACS Investigation of the cellular Fabry disease phenotype using human iPSC-derived cardiomyocytes Chemical and mechanical activation of resident cardiac macrophages in the living myocardial slice ex vivo model Neonatal injury models: integral tools to decipher the molecular basis of cardiac regeneration Development and characterization of anti-fibrotic natural compound similars with improved effectivity Deciphering Pro-angiogenic Transcription Factor Profiles in Hypoxic Human Endothelial Cells by Combined Bioinformatics and in vitro Modeling Development and characterization of anti-fibrotic natural compound similars with improved effectivity Wirkung proinflammatorischer Zytokine auf Betazellen generiert aus humanen pluripotenten Stammzellen MicroRNAs bei COVID-19: kleine Moleküle mit großem Potenzial? Role of endothelial microRNA 155 on capillary leakage in systemic inflammation Novel aspects of age-protection by spermidine supplementation are associated with preserved telomere length DGK and DZHK position paper on genome editing: basic science applications and future perspective Artificial Intelligence Identifies an Urgent Need for Peripheral Vascular Intervention by Multiplexing Standard Clinical Parameters DGK and DZHK position paper on genome editing: basic science applications and future perspective Identification and characterization of “hidden peptides” derived from long noncoding RNAs as fine tuners and/or cancer biomarkers Kardiomyozyten aus humanen induzierten pluripotenten Stammzellen als ein In-vitro-Modell der hypertrophen Kardiomyopathie Reconstruction of the miR-506-Quaking axis in Idiopathic Pulmonary Fibrosis using integrative multi-source bioinformatics Synthese und biologische Evaluierung von Fluoreszenz- und radioaktiv markierten anti-miR-21 Targeting multi-organ fibrosis with natural compound similars and predictive biology A practical guide for investigating cardiac physiology using living myocardial slices Non-coding RNAs: emerging players in cardiomyocyte proliferation and cardiac regeneration AAV capsid engineering for cell targeting and genome editing Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity Comprehensive Bioinformatics Identifies Key microRNA Players in ATG7-Deficient Lung Fibroblasts Identification and functional characterization of anti-fibrotic natural compounds in vitro Identifikation von miR-143 als möglicher Einflussfaktor der Pathogenese von Aortenklappenstenosen = Identification of miR-143 as a major contributor for human stenotic aortic valve disease Inflammatory Drivers of Cardiovascular Disease: Molecular Characterization of Senescent Coronary Vascular Smooth Muscle Cells Integrative Bioinformatic Analyses of Global Transcriptome Data Decipher Novel Molecular Insights into Cardiac Anti-Fibrotic Therapies Preclinical development of anti-senescence therapeutics for the treatment of lung fibrosis Protein moonlighting : myeloid cell-derived BRICK1 enhances tissue repair after acute myocardial infarction Two complementary proteomic analyses uncover new regulators of TBX18 transcriptional function Identification of miR-143 as a Major Contributor for Human Stenotic Aortic Valve Disease TIP 30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation Die Rolle der mitochondrialen long-non-coding RNA als blutbasierte Biomarker für myokardiales Remodeling bei Patienten mit hypertropher Kardiomyopathie Investigation of the regulation and function of long noncoding RNA H19 in hypoxic cardiomyocytes in vitro and after myocardial infarction in vivo Molecular analysis of telomerase in cardiac development and protection Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarction Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity Zirkuläre RNAs: neue Spieler im Kreise der Genregulation Impact of miRNA-146a on vascular remodeling processes Morphogenetic control of zebrafish cardiac looping by Bmp signaling Non-coding RNAs in the Vasculature Non-coding RNAs in the Vasculature Paracrine transfer of regulatory long non-coding RNAs via extracellular vesicles in the cardiovascular system Pharmacological microRNA modulation for the treatment of heart failure

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Thomas Thum (1974-)

SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation

Telomerase is essential for cardiac differentiation and sustained metabolism of human cardiomyocytes

Circular RNA circZFPM2 regulates cardiomyocyte hypertrophy and survival

Dextrans, Pullulan and Lentinan, New Scaffold Materials for Use as Hydrogels in Tissue Engineering

Circulating miR-let7a levels predict future diagnosis of chronic thromboembolic pulmonary hypertension

A pilot study for risk stratification of ventricular tachyarrhythmia in hypertrophic cardiomyopathy with routine echocardiography parameters

Macrophage-based therapeutic approaches for cardiovascular diseases

Contribution of human stem cell-derived cardiomyocyte subtypes to bioartificial cardiac tissue formation and function

Dextrans, Pullulan and Lentinan, New Scaffold Materials for Use as Hydrogels in Tissue Engineering

Activation of the integrated stress response rewires cardiac metabolism in Barth syndrome

Circulating miR-133a-3p defines a low-risk subphenotype in patients with heart failure and central sleep apnea: a decision tree machine learning approach

Skeletal muscle fiber hypercontraction induced by Bothrops asper myotoxic phospholipases A2 ex vivo does not involve a direct action on the contractile apparatus

Cardiovascular complications of diabetes: role of non-coding RNAs in the crosstalk between immune and cardiovascular systems

Characterization of circular RNA circZFPM2 as therapeutic target in hypertrophic cardiomyopathy

Investigating the clinical benefit of circulating long non-coding RNAs to improve the specificity of high-sensitive Troponin T in patients with ACS

Investigation of the cellular Fabry disease phenotype using human iPSC-derived cardiomyocytes

Chemical and mechanical activation of resident cardiac macrophages in the living myocardial slice ex vivo model

Neonatal injury models: integral tools to decipher the molecular basis of cardiac regeneration

Development and characterization of anti-fibrotic natural compound similars with improved effectivity

Deciphering Pro-angiogenic Transcription Factor Profiles in Hypoxic Human Endothelial Cells by Combined Bioinformatics and in vitro Modeling

Development and characterization of anti-fibrotic natural compound similars with improved effectivity

Wirkung proinflammatorischer Zytokine auf Betazellen generiert aus humanen pluripotenten Stammzellen

MicroRNAs bei COVID-19: kleine Moleküle mit großem Potenzial?

Role of endothelial microRNA 155 on capillary leakage in systemic inflammation

Novel aspects of age-protection by spermidine supplementation are associated with preserved telomere length

DGK and DZHK position paper on genome editing: basic science applications and future perspective

Artificial Intelligence Identifies an Urgent Need for Peripheral Vascular Intervention by Multiplexing Standard Clinical Parameters

DGK and DZHK position paper on genome editing: basic science applications and future perspective

Identification and characterization of “hidden peptides” derived from long noncoding RNAs as fine tuners and/or cancer biomarkers

Kardiomyozyten aus humanen induzierten pluripotenten Stammzellen als ein In-vitro-Modell der hypertrophen Kardiomyopathie

Reconstruction of the miR-506-Quaking axis in Idiopathic Pulmonary Fibrosis using integrative multi-source bioinformatics

Synthese und biologische Evaluierung von Fluoreszenz- und radioaktiv markierten anti-miR-21

Targeting multi-organ fibrosis with natural compound similars and predictive biology

A practical guide for investigating cardiac physiology using living myocardial slices

Non-coding RNAs: emerging players in cardiomyocyte proliferation and cardiac regeneration

AAV capsid engineering for cell targeting and genome editing

Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity

Comprehensive Bioinformatics Identifies Key microRNA Players in ATG7-Deficient Lung Fibroblasts

Identification and functional characterization of anti-fibrotic natural compounds in vitro

Identifikation von miR-143 als möglicher Einflussfaktor der Pathogenese von Aortenklappenstenosen = Identification of miR-143 as a major contributor for human stenotic aortic valve disease

Inflammatory Drivers of Cardiovascular Disease: Molecular Characterization of Senescent Coronary Vascular Smooth Muscle Cells

Integrative Bioinformatic Analyses of Global Transcriptome Data Decipher Novel Molecular Insights into Cardiac Anti-Fibrotic Therapies

Preclinical development of anti-senescence therapeutics for the treatment of lung fibrosis

Protein moonlighting : myeloid cell-derived BRICK1 enhances tissue repair after acute myocardial infarction

Two complementary proteomic analyses uncover new regulators of TBX18 transcriptional function

Identification of miR-143 as a Major Contributor for Human Stenotic Aortic Valve Disease

TIP 30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation

Die Rolle der mitochondrialen long-non-coding RNA als blutbasierte Biomarker für myokardiales Remodeling bei Patienten mit hypertropher Kardiomyopathie

Investigation of the regulation and function of long noncoding RNA H19 in hypoxic cardiomyocytes in vitro and after myocardial infarction in vivo

Molecular analysis of telomerase in cardiac development and protection

Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarction

Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study

Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity

Zirkuläre RNAs: neue Spieler im Kreise der Genregulation

Impact of miRNA-146a on vascular remodeling processes

Morphogenetic control of zebrafish cardiac looping by Bmp signaling

Non-coding RNAs in the Vasculature

Non-coding RNAs in the Vasculature

Paracrine transfer of regulatory long non-coding RNAs via extracellular vesicles in the cardiovascular system

Pharmacological microRNA modulation for the treatment of heart failure